ArticleFrontiers in oncology2022

Should we adopt an automated de-centralized model of chimeric antigen receptor- T cells manufacturing for low-and middle-income countries? A real world perspective.

Sharanya Ramakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.